Metabolic and OXPHOS Activities Quantified by Temporal ex vivo Analysis Display Patient-Specific Metabolic Vulnerabilities in Human Breast Cancers

Frontiers in Oncology
Andre KoitTuuli Kaambre

Abstract

Research on mitochondrial metabolism and respiration are rapidly developing areas, however, efficient and widely accepted methods for studying these in solid tumors are still missing. Here, we developed a new method without isotope tracing to quantitate time dependent mitochondrial citrate efflux in cell lines and human breast cancer samples. In addition, we studied ADP-activated respiration in both of the sample types using selective permeabilization and showed that metabolic activity and respiration are not equally linked. Three times lower amount of mitochondria in scarcely respiring MDA-MB-231 cells convert pyruvate and glutamate into citrate efflux at 20% higher rate than highly respiring MCF-7 mitochondria do. Surprisingly, analysis of 59 human breast cancers revealed the opposite in clinical samples as aggressive breast cancer subtypes, in comparison to less aggressive subtypes, presented with both higher mitochondrial citrate efflux and higher respiration rate. Additionally, comparison of substrate preference (pyruvate or glutamate) for both mitochondrial citrate efflux and respiration in triple negative breast cancers revealed probable causes for high glutamine dependence in this subtype and reasons why some of these t...Continue Reading

References

Jan 15, 2003·Experimental Physiology·Florence AppaixValdur Saks
Feb 24, 1956·Science·O WARBURG
Jan 1, 1956·Advances in Enzymology and Related Subjects of Biochemistry·B CHANCE, G R WILLIAMS
Oct 18, 2005·Cancer Cell·Georgia HatzivassiliouCraig B Thompson
Nov 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ralph J DeBerardinisCraig B Thompson
Jun 10, 2008·Nature Protocols·Andrey V KuznetsovWolfram S Kunz
May 14, 2009·Journal of the National Cancer Institute·Maggie C U CheangTorsten O Nielsen
May 14, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Stuart J Schnitt
Oct 12, 2011·Annual Review of Cell and Developmental Biology·Sophia Y Lunt, Matthew G Vander Heiden
Nov 22, 2011·Nature·Christian M MetalloGregory Stephanopoulos
Jul 28, 2012·Journal of Bioenergetics and Biomembranes·Tuuli KaambreValdur Saks
Oct 27, 2012·Oncotarget·Olga Catalina-RodriguezMaria Laura Avantaggiati
Sep 28, 2013·Journal of Bioenergetics and Biomembranes·Aleksandr KlepininTuuli Kaambre
Feb 14, 2014·Molecular Cancer Therapeutics·Matt I GrossMark K Bennett
Feb 13, 2015·Science Translational Medicine·Sriram VennetiCraig B Thompson
Jul 28, 2015·Cell Metabolism·Andrew M IntlekoferCraig B Thompson
Jan 16, 2016·Cell Metabolism·Natalya N Pavlova, Craig B Thompson
Jan 19, 2016·Trends in Biochemical Sciences·Maria V Liberti, Jason W Locasale
Feb 9, 2016·Cell·Christopher T HensleyRalph J DeBerardinis
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Dec 4, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Philippe Icard, Hubert Lincet
Apr 11, 2017·Trends in Cancer·Ahmad A CluntunJason W Locasale
Aug 7, 2017·Oxidative Medicine and Cellular Longevity·Andre KoitTuuli Kaambre
Jun 29, 2018·Nature Cell Biology·Jessica B Spinelli, Marcia C Haigis
Nov 22, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·Lan HuangGuangyong Peng
Jul 23, 2020·Nature Metabolism·Ralph J DeBerardinis, Navdeep S Chandel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
confocal microscopy

Software Mentioned

Mitogro
ImageJ

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.